Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study

NCT04009525 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

823

Enrollment

OTHER

Sponsor class

Conditions

Thalassemia Major

Interventions

DRUG: Busulfan
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Thymoglobulin
DRUG: cyclosporine A
DRUG: Mycophenolate mofetil
DRUG: Tacrolimus
DRUG: Methotrexate

Sponsor

First Affiliated Hospital of Guangxi Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]